(Reuters) – Merck & Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus Biosciences Inc as …
Topic:
10.3%
-
-
By Juliette Portala (Reuters) – Industries helping the world shift to net-zero emissions could be worth $10.3 trillion to the global economy by 2050, sustainable development consultancy Arup and economics …